Facts in cancer genetics

Patient Education and Counseling

Volumn 32, Issue 1-2, 1997, Pages 9-17

  Cornelisse, C J ^a   Devilee, P ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cancer susceptibility genes; Genetics; Hereditary cancer risk

Indexed keywords

GENE PRODUCT; ONCOPROTEIN;

ARTICLE; BASE MISPAIRING; CANCER RISK; CANCER SUSCEPTIBILITY; CHROMOSOME ABERRATION; CHROMOSOME MAP; DNA REPAIR; ENVIRONMENTAL FACTOR; FAMILIAL CANCER; GENE MUTATION; GERM LINE; HETEROZYGOTE; HUMAN; ONCOGENE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

COUNSELING; DNA REPAIR; GENES, TUMOR SUPPRESSOR; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEOPLASMS; NEOPLASTIC SYNDROMES, HEREDITARY; ONCOGENES; PATIENT EDUCATION;

EID: 0030853733     PISSN: 07383991     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-3991(97)00059-1     Document Type: Article

References (37)

1. Lynch HT, editor. Genetics and breast cancer. New York: Van Nostrand Reinhold, 1981.
2. Lynch HT, Marcus JM, Watson P, Conway T, Fitzsimmons ML, Lynch JF. Genetic epidemiology of breast cancer. In: Lynch HT, Hirayama T, editors. Genetic epidemiology of cancer. Boca Raton: CRC Press, 1989:289-332.
3. von Hansemann D. Ueber asymmetrische Zelltheilung in Epithelkrebsen und deren biologische Bedeutung. Virchows Arch Pathol Anat Physiol. 119:1890;299-316.
4. Boveri T. Zur Frage der Entstehung maligner Tumoren. Jena: Gustav Fischer, 1914.
5. Cairns J. Mutation selection and the natural history of cancer. Nature. 225:1975;197-200.
6. Nowell P.C., Hungerford D.A. A minute chromosome in human chronic granulocytic leukaemia. Science. 132:1960;613-616.
7. Groffen J., Stephenson J.R., Heisterkamp N., de Klein A., Bartram C.R., Grosveld G. Philadelphia chromosomal breakpoints are clustered with a limited region, bcr, on chromosome 22. Cell. 36:1984;93-99.
8. Bishop J.M. Cellular oncogenes and retroviruses. Annu. Rev. Biochem. 52:1983;301-354.
9. Varmus H. The molecular genetics of cellular oncogenes. Annu. Rev. Genet. 18:1984;553-612.
10. Hunter T. Oncoprotein networks. Cell. 88:1997;333-346.
11. Arends M.J., Wyllie A.H. Apoptosis: mechanisms and roles in pathology. Int. Rev. Exp. Pathol. 32:1991;223-254.
12. Weinberg R.A. The retinoblastoma protein and cell cycle control. Cell. 81:1995;323-330.
13. Sherr C.J. Cancer cell cycles. Science. 274:1996;1672-1677.
14. Slamon D.J., Clark G.M., Wong S.G., Levin W.J., Ullrich A., McGuire W.L. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science. 235:1987;177-182.
15. van de Vijver M.J., van de Bersselaar R., Devilee P., Cornelisse C., Peterse J., Nusse R. Amplification of the neu (c-erbB-2) oncogene in human mammary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene. Mol Cell Biol. 7:1987;2019-2023.
16. Mulligan L., Healey C., Clayton D., Kwok J., Gardner E., Ponder M., Frilling A., Jackson C., Lehnert H., Neumann H., Thibodeau S., Ponder B. Specific mutations of the RET proto-oncogene are related to disease phenotytpe in MEN2a and FMTC. Nat Genet. 6:1994;70-74.
17. Harris H., Klein G. Malignancy in somatic cell hybrids. Nature. 224:1969;1314-1316.
18. Knudson A.G. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA. 68:1971;820-823.
19. Friend S.H., Bernards R., Rogelj S., Weinberg R.A., Rapaport J.M., Albert D.M., Drya T.P. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature. 323:1986;643-646.
20. Levine AJ. p53, the cellular gate keeper for growth and division. Cell 1997:323-31.
21. Li F.P., Fraumeni J.F. Soft-tissue sarcomas, breast cancer and other neoplasms. Ann Intern Med. 71:1969;747-752.
22. Malkin D., Li F.P., Strong L.C.et al. Germline p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science. 250:1990;1233-1238.
23. Aaltonen L.A., Peltomäki P., Leach F.S.et al. Clues to the pathogenesis of familial colorectal cancer. Science. 260:1993;810-812.
24. Fishel R., Kolodner R.D. Identification of mismatch repair genes and their role in the development of cancer. Curr Opin Genet Dev. 5:1995;382-395.
25. Modrich P. Mismatch repair, genetic stability and cancer. Science. 266:1994;1959-1960.
26. Loeb L.A. Microsatellite instability: model of mutator phenotype in cancer. Cancer Res. 54:1994;5059-5063.
27. Fearon E.R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 61:1990;759-767.
28. Kinzler K.W., Vogelstein B. Lessons from hereditary colorectal cancer. Cell. 87:1996;159-170.
29. Nowell P.C. The clonal evolution of tumor cell populations. Science. 194:1976;23-28.
30. Miki Y., Swensen J., Shattuck-Eidens D.et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 266:1994;66-711.
31. Wooster R., Bignell F.G., Lancaster J.et al. Identification of the breast cancer susceptibility gene BRCA2. Nature. 378:1995;789-792.
32. Eccles D.M., van der Luijt R., Breukel C.et al. Hereditary desmoid disease due to a frameshift at codon 1924 of the APC gene. Am J Hum Genet. 59:1996;1193-1201.
33. Van Wezel T., Stassen A.P.M., Moen C.J.A., Hart A.A.M., van der Valk M.A., Demant P. Gene interaction and single gene effects in colon tumour susceptibility in mice. Nat Genet. 14:1996;468-470.
34. Easton D.F., Ford D., Bishop D.T., The Breast Cancer Linkage Consortium Breast and ovarian cancer incidence in BRCA1 mutation carriers. Am J Hum Genet. 56:1995;265-271.
35. Easton D., Ford D., Peto J. Inherited susceptibility to breast cancer. Cancer Surv. 18:1993;95-113.
36. Hacia J.G., Brody L.C., Chee M.S., Fodor S.P.A., Collins F.S. Detection of heterozygous mutations in BRCA1 using high density oligonucleotide arrays and two-colour fluorescence analysis. Nature Genet. 14:1996;441-447.
37. Trichopoulos D., Li F.P., Hunter D.J. What causes cancer? Sci Am. 275:1996;80-87.